Is There a Role for Cellular Therapy in Chronic Lymphocytic Leukemia?

被引：4
|
作者：
Dreger, Peter [1 ]
机构：
[1] Heidelberg Univ, Dept Med 5, Neuenheimer Feld 410, D-69120 Heidelberg, Germany
来源：
CANCER JOURNAL | 2021年 / 27卷 / 04期
关键词：
CAR T-cell therapy; chronic lymphocytic leukemia; CLL; transplantation; BONE-MARROW-TRANSPLANTATION; MINIMAL RESIDUAL DISEASE; MODIFIED T-CELLS; RETROSPECTIVE ANALYSIS; RICHTERS-SYNDROME; FOLLOW-UP; OUTCOMES; CLL; GUIDELINES; COVID-19;
D O I：
10.1097/PPO.0000000000000532
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Despite multiple advances in the treatment landscape of chronic lymphocytic leukemia (CLL) during recent years, cellular therapies, such as allogeneic hematopoietic cell transplantation and chimeric antigen-engineered T cells, represent valuable therapeutic options for patients with multiply relapsed or poor-risk disease. This brief overview will summarize current results of cellular therapies in CLL including Richter transformation, suggest an indication algorithm and strategies for performing cellular therapies in these conditions, and discuss the impact of COVID-19 (coronavirus disease 2019) on allogeneic hematopoietic cell transplantation and chimeric antigen-engineered T cells in CLL.
引用
收藏
页码：297 / 305
页数：9
相关论文
共 50 条
  • [1] Cellular immune therapy for chronic lymphocytic leukemia
    Kater, Arnon P.
    van Oers, Marinus H. J.
    Kipps, Thomas J.
    [J]. BLOOD, 2007, 110 (08) : 2811 - 2818
  • [2] Advancing therapy for chronic lymphocytic leukemia - The role of rituximab
    Hillmen, P
    [J]. SEMINARS IN ONCOLOGY, 2004, 31 (01) : 22 - 26
  • [3] Cellular Therapy Advances in Chronic Lymphocytic Leukemia and Richter's Syndrome
    Bajwa, Amneet
    Voorhees, Timothy J.
    Kittai, Adam S.
    [J]. CURRENT PROBLEMS IN CANCER, 2022, 46 (01)
  • [4] THE ROLE OF MAINTENANCE THERAPY IN THE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
    Kuvshinov, A.
    Voloshin, S.
    Martynkevich, I.
    Garifullin, A.
    Kleina, E.
    [J]. HAEMATOLOGICA, 2017, 102 : 717 - 717
  • [5] Cellular therapy in chronic lymphocytic leukemia: have we advanced in the last decade?
    Katz, Ofrat Beyar
    Yehudai-Ofir, Dana
    Zuckerman, Tsila
    [J]. ACTA HAEMATOLOGICA, 2024, 147 (01) : 101 - 114
  • [6] Cellular origin and pathophysiology of chronic lymphocytic leukemia
    Seifert, Marc
    Sellmann, Ludger
    Bloehdorn, Johannes
    Wein, Frederik
    Stilgenbauer, Stephan
    Duerig, Jan
    Kueppers, Ralf
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2012, 209 (12): : 2183 - 2198
  • [7] Antibody therapy for chronic lymphocytic leukemia
    Christian, Beth A.
    Lin, Thomas S.
    [J]. SEMINARS IN HEMATOLOGY, 2008, 45 (02) : 95 - 103
  • [8] Update on Therapy of Chronic Lymphocytic Leukemia
    Gribben, John G.
    O'Brien, Susan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (05) : 544 - 550
  • [9] Bendamustine therapy in chronic lymphocytic leukemia
    Masiello, David
    Tulpule, Anil
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (10) : 1687 - 1698
  • [10] Personalized therapy for chronic lymphocytic leukemia
    Rogalinska, Malgorzata
    Blonski, Jerzy
    Goralski, Pawel
    Robak, Pawel
    Franiak-Pietryga, Ida
    Wawrzyniak, Ewa
    Rogalska, Aneta
    Maciejewski, Henryk
    Koceva-Chyla, Aneta
    Piekarski, Henryk
    Robak, Tadeusz
    Kilianska, Zofia M.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2015, 36 : S115 - S115
12345